enquiry@dsij.in |+91 9240904920
SENSEX-570.59
71,909.7-0.79%

Emcure Pharmaceuticals Ltd.

(Industry - Pharmaceuticals & Drugs)

₹1,943.6

1.40 (0.07%)
BSE: 544210 | NSE: EMCURE
Website: http://www.emcure.com

Today High/Low

L
H
₹1,918.6₹1,973

52 Week High/Low

L
H
₹1,305.5₹2,015.75

About Company

Emcure Pharmaceuticals Limited develops, manufactures and markets pharmaceutical products in India and overseas. Its business combines in-house research, product development and manufacturing with domestic and international commercial platforms and relationships with multinational pharmaceutical companies. Its capabilities cover oral medicines, injectables, active pharmaceutical ingredients, peptides and biotherapeutics, while R&D spans biologics, complex generics, novel drug delivery systems and long-acting injectables. The group has 13 manufacturing facilities in India and a presence in more than 80 countries.

Market Cap.
₹36,872.16 Cr.
P/E Ratio
36.19
P/B Ratio
9.46
Current Price
₹1,943.6
Open
₹1,936
High
₹1,973
Prev Close
₹1,942.2
Quantity Traded
3,437
52 Week High
₹2,015.75
52 Week Low
₹1,305.5
Dividend Yield
0.19%
EBITDA Margin
20.46%
ROE
20.64%
Book Value
₹205.51
Face Value
₹10
MindshareMutual FundQuarterly ResultsInterviewsIPO AnalysisMultibaggerPenny StocksDividendBonus & Stock SplitSMEPersonal FinanceSwing Trading

If you want to stay updated with the Share Market News Today, keep a close watch on the Indian Stock Market Today with real time movements like Sensex Today Live and overall trends. Investors tracking IPO Allotment Status, IPO News Today, or the Latest IPO India can also follow daily updates along with BSE Share Price Live data. Whether you are learning How To Invest in Stock Market in India, preparing for a Market Crash Today, or searching for the Best Stocks to Buy in India, insights on Top Gainers Today India, Top Losers Today India, Trending Stocks India and Long Term Stocks India help in making informed investment decisions.

Stay informed, stay disciplined, and make smarter investment choices with timely and reliable market insights.